TPM1 variants in HCM cohorts


The table below lists the 66 rare (MAF<0.0001 in ExAC) protein-altering TPM1 variants identified in a cohort of 4447 HCM patients (1535 patients from OMGL, 2912 patients from LMM). When this rare variant frequency of 0.01484 is compared with a background population rate of 0.00086, there is a statistically significant case excess of 0.01398 (p<0.0001), which suggests that approximately 62 of these variants may be pathogenic.


Variant Type:      All protein-altering variants     -     Truncating variants     -     Non-Truncating variants
Source:      Combined (OMGL + LMM)     -     OMGL     -     LMM



No. Variant (CDS) Variant (Protein) Variant Type Cases (4447)OMGL classLMM class ExAC frequency
1. c.676A>C p.K226Qmissense 1VUS favour pathogenic (1)0.000000
2. c.252C>G p.D84Emissense 1VUS (1)0.000008
3. c.677A>G p.K226Rmissense 1VUS (1)0.000000
4. c.82G>A p.D28Nmissense 1VUS (1)0.000000
5. c.790A>G p.K264Emissense 1Likely Pathogenic (1)0.000000
6. c.64G>A p.A22Tmissense 2VUS favour pathogenic (2)0.000000
7. c.850A>G p.I284Vmissense 2VUS (1)VUS (1)0.000000
8. c.841A>G p.M281Vmissense 2VUS (2)0.000026
9. c.58G>A p.D20Nmissense 1VUS (1)0.000000
10. c.559G>C p.E187Qmissense 1Likely Pathogenic (1)0.000000
11. c.475G>A p.D159Nmissense 1VUS (1)0.000000
12. c.302G>C p.R101Pmissense 1VUS (1)0.000000
13. c.761A>G p.D254Gmissense 1VUS (1)0.000000
14. c.574G>A p.E192Kmissense 13Likely Pathogenic (13)0.000000
15. c.829G>A p.A277Tmissense 2VUS favour benign (2)0.000034
16. c.82G>C p.D28Hmissense 3VUS (1)VUS favour pathogenic (2)0.000000
17. c.655G>A p.D219Nmissense 1Likely Pathogenic (1)0.000000
18. c.305C>A p.A102Dmissense 1VUS favour pathogenic (1)0.000000
19. c.699G>C p.K233Nmissense 1VUS (1)0.000000
20. c.715G>A p.A239Tmissense 1VUS (1)0.000000
21. c.46G>C p.E16Qmissense 1Likely Pathogenic (1)0.000000
22. c.548C>T p.A183Vmissense 3VUS (2)VUS (1)0.000000
23. c.762T>G p.D254Emissense 1Likely Pathogenic (1)0.000000
24. c.481A>G p.K161Emissense 1VUS (1)0.000000
25. c.774C>G p.D258Emissense 1VUS (1)0.000000
26. c.644C>T p.S215Lmissense 4VUS (1)VUS favour pathogenic (3)0.000008
27. c.842T>C p.M281Tmissense 1VUS (1)0.000000
28. c.343G>A p.E115Kmissense 1Likely Pathogenic (1)0.000000
29. c.461T>C p.I154Tmissense 1Pathogenic (1)0.000000
30. c.457C>G p.H153Dmissense 1Pathogenic (1)0.000000
31. c.746T>G p.L249Wmissense 2Likely Pathogenic (2)0.000000
32. c.797A>G p.K266Rmissense 2VUS (2)0.000042
33. c.523G>A p.D175Nmissense 8Pathogenic (4)Pathogenic (4)0.000000
34. c.835A>C p.N279Hmissense 1VUS favour pathogenic (1)0.000000

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.

2. Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, Cox SW, DePalma SR, Ho CY, Seidman JG, Seidman CE, Rehm HL. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med. 2015 Nov;17(11):880-8.